Skip to main content

Table 2 Main patient and tumor characteristics

From: Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery

Age (years)

median (range)

66 (51-87)

Histology

Ductal/other

48/9

Estrogen receptor

RE+/RE-

52/5

Progesteron receptor

RP+/RP-

45/12

Tumor stage

Tis/T1/T2

1/48/8

Nodal stage

N0/N1

54/3

Chemotherapy

yes/no

15/42

 

CMF

5

 

FEC

5

 

EC

1

 

EC+ Docetaxel

4

Hormone-therapy

yes/no

52/5

  1. Abbreviations: CMF: Cyclophosphamide (600 mg/m2, Methotrexate 40 mg/m2, 5-FU 600 mg/m2 d 1 and d 8 q 4 weeks Ă— 6); FEC (5-FU 600 mg/m2, Epirubicin 60 mg/m2, Cyclophosphamide 600 mg/m2 d 1 q 3 weeks Ă— 6); EC (Epirubicin 60 mg/m2, Cyclophosphamide 600 mg/m2 d1 q 3 weeks Ă— 4); EC+ Docetaxel : EC followed by Docetaxel (100 mg/m2 d1 q 3 weeks Ă— 4)